Are women with thalassemia prone to heavy menstrual bleeding (menorrhagia)?

Thalassemia and Heavy Menstrual Bleeding

Women with thalassemia are NOT inherently prone to heavy menstrual bleeding (menorrhagia) due to their underlying disease; in fact, the majority experience impaired fertility and hypogonadism that often results in reduced or absent menstruation. 1

Understanding the Menstrual Pattern in Thalassemia

The key pathophysiology in thalassemia major relates to iron overload-induced hypogonadism, not bleeding disorders:

• Most women with thalassemia major have impaired fertility caused by hypogonadism and often require induction of ovulation to conceive 1
• Iron deposition in the pituitary and gonads leads to endocrine dysfunction, typically resulting in amenorrhea or oligomenorrhea (reduced menstruation), not heavy bleeding
• Well-transfused and adequately chelated women may maintain spontaneous fertility and more normal menstrual patterns 1

Important Clinical Distinction

If a woman with thalassemia presents with heavy menstrual bleeding, this warrants investigation for alternative causes rather than attributing it to the thalassemia itself:

Consider these etiologies:

• Coexisting bleeding disorders (von Willebrand disease, platelet function defects) - present in up to 30% of women with HMB in general populations 2
• Structural uterine pathology (fibroids, polyps, adenomyosis)
• Endocrine disorders (thyroid dysfunction, PCOS) - thyroid abnormalities in 3% and PCOS in 8% of HMB cases 2
• Coagulopathy from liver disease secondary to iron overload
• Thrombocytopenia from hypersplenism (in non-splenectomized patients)

Critical Pitfall to Avoid

Do not assume that anemia in a woman with thalassemia and menstrual bleeding is solely due to her baseline thalassemia. While thalassemia patients have chronic anemia, superimposed iron deficiency from true menorrhagia can worsen their clinical status. However, this scenario is uncommon given the typical hypogonadal state and existing iron overload from transfusions.

Practical Management Approach

When evaluating menstrual patterns in thalassemia patients:

1. Assess endocrine function: Check FSH, LH, estradiol, and thyroid function to evaluate degree of hypogonadism
2. Review chelation adequacy: Poor chelation leads to worse endocrine dysfunction
3. If HMB is present: Investigate as you would in any woman - pelvic ultrasound, coagulation studies, consider structural causes
4. Monitor iron status carefully: These patients already have transfusional iron overload; additional iron loss from true HMB creates a complex management scenario

The evidence clearly shows that pregnancy-related complications in thalassemia include cardiac issues, gestational diabetes, preeclampsia, and hypertension 1, but heavy menstrual bleeding is not listed among the characteristic complications of the disease itself.